Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Learn how Mounjaro (tirzepatide) may reverse pre-diabetes in young adults in India, its benefits, and why early action is key.

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

New research reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Experts urge ...

Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

Appetite suppression will always be at its highest on days one to three after injecting Mounjaro and by days six to seven, ...

In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...